Details

Autor(en) / Beteiligte

• Azeeza Gassim Abdulmajid Eswikar
• Eman Abdalla Mohamed El-shorbagy
• Saad, Mohamed S S
• Mahmoud Hassan Mahmoud

Titel

Role of cGMP, NO and PDE5 in Hypertension: Review Article

Ist Teil von

• NeuroQuantology, 2022-01, Vol.20 (13), p.365

Ort / Verlag

Bornova Izmir: NeuroQuantology

Erscheinungsjahr

2022

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• Cyclic GMP (cGMP) is a ubiquitous intracellular second messenger that mediates a wide spectrum of physiologic processes in multiple cell types within the cardiovascular and nervous systems. Synthesis of cGMP occurs either by NO-sensitive guanylyl cyclases in response to nitric oxide or by membrane-bound guanylyl cyclases in response to natriuretic peptides and has been shown to regulate blood pressure homeostasis by influencing vascular tone, sympathetic nervous system, and sodium and water handling in the kidney. Several cGMPs degrading phosphodiesterases (PDEs), including PDE1 and PDE5, play an important role in the regulation of cGMP signaling. Recent findings revealed that increased activity of cGMP-hydrolyzing PDEs contribute to the development of hypertension. In this review, we will summarize recent research findings regarding the cGMP/PDE signaling in the vasculature which is associated with the development and maintenance of hypertension.